Literature DB >> 30538606

Use of Obeticholic Acid in Patients With Primary Biliary Cholangitis.

Robert S Brown1.   

Abstract

Entities:  

Year:  2018        PMID: 30538606      PMCID: PMC6284343     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  5 in total

1.  Primary biliary cirrhosis.

Authors:  Keith D Lindor; M Eric Gershwin; Raoul Poupon; Marshall Kaplan; Nora V Bergasa; E Jenny Heathcote
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

2.  EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.

Authors: 
Journal:  J Hepatol       Date:  2017-04-18       Impact factor: 25.083

Review 3.  Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Expert Opin Pharmacother       Date:  2014-01-02       Impact factor: 3.889

4.  A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.

Authors:  Frederik Nevens; Pietro Andreone; Giuseppe Mazzella; Simone I Strasser; Christopher Bowlus; Pietro Invernizzi; Joost P H Drenth; Paul J Pockros; Jaroslaw Regula; Ulrich Beuers; Michael Trauner; David E Jones; Annarosa Floreani; Simon Hohenester; Velimir Luketic; Mitchell Shiffman; Karel J van Erpecum; Victor Vargas; Catherine Vincent; Gideon M Hirschfield; Hemant Shah; Bettina Hansen; Keith D Lindor; Hanns-Ulrich Marschall; Kris V Kowdley; Roya Hooshmand-Rad; Tonya Marmon; Shawn Sheeron; Richard Pencek; Leigh MacConell; Mark Pruzanski; David Shapiro
Journal:  N Engl J Med       Date:  2016-08-18       Impact factor: 91.245

5.  Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study.

Authors:  Willem J Lammers; Henk R van Buuren; Gideon M Hirschfield; Harry L A Janssen; Pietro Invernizzi; Andrew L Mason; Cyriel Y Ponsioen; Annarosa Floreani; Christophe Corpechot; Marlyn J Mayo; Pier M Battezzati; Albert Parés; Frederik Nevens; Andrew K Burroughs; Kris V Kowdley; Palak J Trivedi; Teru Kumagi; Angela Cheung; Ana Lleo; Mohamad H Imam; Kirsten Boonstra; Nora Cazzagon; Irene Franceschet; Raoul Poupon; Llorenç Caballeria; Giulia Pieri; Pushpjeet S Kanwar; Keith D Lindor; Bettina E Hansen
Journal:  Gastroenterology       Date:  2014-08-23       Impact factor: 22.682

  5 in total
  1 in total

1.  Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis.

Authors:  Christoph Schramm; Heiner Wedemeyer; Andrew Mason; Gideon M Hirschfield; Cynthia Levy; Kris V Kowdley; Piotr Milkiewicz; Ewa Janczewska; Elena Sergeevna Malova; Johanne Sanni; Phillip Koo; Jin Chen; Subhajit Choudhury; Lloyd B Klickstein; Michael K Badman; David Jones
Journal:  JHEP Rep       Date:  2022-07-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.